Skip to main content
. 2025 Sep 16;14(18):1450. doi: 10.3390/cells14181450
ICIs immune checkpoint inhibitors
IIH ICI-induced hypophysitis
PitNETs pituitary neuroendocrine tumors
PDL-1 programmed cell death ligand 1
FDA Food and Drug Administration
CTLA-4 cytotoxic T-lymphocyte-associated antigen 4
LAG-3 lymphocyte-activating gene-3
PD-1 programmed cell death protein 1
APCs antigen presenting cells
MHC major histocompatibility complex
TCR T-cell receptor
IRAK1 interleukin-1 receptor-associated kinase 1
LINH lymphocytic infundibulo-neurohypophysitis
AVP arginine vasopressin
irAEs immune-related adverse events
ADCC antibody-dependent cellular cytotoxicity
GNAL guanine nucleotide-binding protein G (olf) subunit alpha
ITM2B integral membrane protein 2B
ACTH adrenocorticotropic hormone
POMC Proopiomelanocortin
NK natural killer